The Uromigos
Education Podcasts
Broadcasting the latest developments in GU cancer Hosted by Brian Rini and Tom Powles Brian Rini MD is a Professor of Cancer Research and Professor of Medicine (Hematology/Oncology), Vanderbilt-Ingram Cancer Center Tom Powles is the Director of Barts Cancer Centre, St Bartholomew's Hospital and Professor of Genitourinary Oncology, Queen Mary University of London
Location:
United Kingdom
Genres:
Education Podcasts
Description:
Broadcasting the latest developments in GU cancer Hosted by Brian Rini and Tom Powles Brian Rini MD is a Professor of Cancer Research and Professor of Medicine (Hematology/Oncology), Vanderbilt-Ingram Cancer Center Tom Powles is the Director of Barts Cancer Centre, St Bartholomew's Hospital and Professor of Genitourinary Oncology, Queen Mary University of London
Twitter:
@Uromigos
Language:
English
Website:
https://anchor.fm/the-uromigos
Episodes
Episode 416: ASCO 2025 Preview
5/19/2025
Silke, Tom and Brian discuss what they are looking forward to at ASCO 2025
Duration:00:40:43
Episode 415: Uromigos Score 前立腺がん編
5/12/2025
日本と海外の違いはあるのか？mHSPCとmCRPCのUromigos Scoreについて激論！！
Duration:00:44:02
Episode 414: Uromigos score en cáncer de próstata metastasico - más allá de las guías clínicas
5/12/2025
Edición especial en castellano con Alfonso Gómez de Liaño y Guillermo de Velasco. David Lorente da su visión sobre el nuevo Uromigos Score, que clasifica distintas opciones de tratamiento en varios escenarios de cáncer de próstata metastásico
Duration:00:28:23
Episode 413: The Uromigos Score for Advanced Prostate Cancer
5/12/2025
Silke and Chris joins us to discuss our latest 'Uromigos Score' in which experts score the value of treatments for advanced prostate cancer. Several interesting themes emerge.
Duration:00:37:02
Episode 410: AUA 2025 - BOND-003 Cohort C: Cretostimogene in BCG-Unresponsive NMIBC
5/5/2025
Mark Tyson from Mayo Clinic joins the podcast to discuss this replicating adenovirus and a high CR rate in BCG-unresponsive NMIBC
Duration:00:28:52
Episode 411: AUA 2025 - TAR-200 Monotherapy in BCG-Unresponsive NMUIBC from SunRISe-1n
5/5/2025
Joe Jacob joins the show to discuss the longer-term follow up of this cohort from SunRISe-1. We discuss definitions of CR and regulatory issues around drug approval in this space as well.
Duration:00:37:20
Episode 411: Live from EIKCS in Amsterdam - RCC Highlights
5/3/2025
Viktor Grunwald joins to discuss the new data session from EIKCS
Duration:00:20:26
Episode 410: AUA 2025 - BOND-003 Cohort C: Crestimogene in BCG-Unresponsive NMIBC
4/27/2025
Mark Tyson from Mayo Clinic joins the podcast to discuss this replicating adenovirus and a high CR rate in BCG-unresponsive NMIBC
Duration:00:29:08
Episode 408: AUA 2025 - CREST - BCG +/- Sasanlimab in high-risk NMIBC
4/26/2025
Neal Shore joins the show to discuss these exciting data from the American Urological Association Annual Meeting
Duration:00:47:27
Episode 407: Uromigos Japan - European Delphi Study of mRCCについてdiscussion
4/23/2025
今月Eur Urol OncolにPublishされたヨーロッパのエキスパートによるmRCCのコンセンサスについて日本との違いについて深い議論をしました！！
Duration:00:33:04
Episode 407: Drug Development in China: Part 2 of 2
4/21/2025
Part 2 of our series dives deeper into the explosion of ADC clinical drug development in China
Duration:00:25:21
Episode 406: Drug Development in China: Part 1 of 2
4/14/2025
Drs. Dingwei Ye and Yao Zhu from China join the show to talk about drug development in China amid the recent surge of GU clinical trials.
Duration:00:30:02
Episode 405: The Good News About Cancer podcast
4/11/2025
Drs. Alicia Morgans and Chuck Ryan join the show to talk about their new podcast.
Duration:00:17:53
Episode 404: 177 Lu-PSMA Pre-chemotherapy in mCRPC. Final Podcast from the Canary Islands
4/7/2025
Elena Castro joins Tom and Brian on the day after Pluvicto approval pre-chemotherapy in the US to discuss the PSMA Fore data and application in clinical practice.
Duration:00:27:09
Episode 403: ADCs in Bladder Cancer. Part 2 from the Canary Islands
4/2/2025
Ignacio Duran continues his discussion with Brian and Tom regarding novel ADCS in bladder cancer
Duration:00:37:41
Episode 402: Uromigos en Espanol: Futuro del carcinoma de células renales
3/31/2025
Cristina Suárez analiza los próximos ensayos clínicos que podrían transformar el manejo del cáncer renal en los próximos años: nuevas combinaciones adyuvantes y estrategias perioperatorias, el uso de tripletes enprimera línea y la integración de inhibidores de HIF con TKIs, entre otros.
Duration:00:25:12
Episode 401: ADCs in Bladder Cancer. Part 1 from the Canary Islands
3/29/2025
Ignacio Duran joins the show to discuss the landscape of established ADCs in urothelial cancer and challenges of drug development in this setting.
Duration:00:30:29
Episode 400: The Uromigos Score for Urothelial Cancer
3/28/2025
Live from the Canary Islands 'Big Idea' talk from Tom, we discuss the new Uromigos Score which ranks different treatment options in several urothelial cancer settings.
Duration:00:20:19
Episode 399: A PD1/VEGF Bispecific in Lung Cancer - Lessons for GU Cancers?
3/24/2025
Dr. John Heymach from MD Andersons joins us to discuss a novel PD1/VEGF bispecific agent in lung cancer and if there are applicaitons in GU malignancies.
Duration:00:36:44
Episode 398: Reflections on the Felix Feng Symposium at ASCO GU
3/17/2025
Chuck Ryan joins us to discuss his interview with Felix and reflects on his keynote address at ASCO GU 2025.
Duration:00:32:05